United States Kyphosis Treatment Market Projected to Reach US$ 1.8 Billion by 2031, Driven by Rising Prevalence of Spinal Deformities| DataM Intelligence

Leander, Texas and TOKYO, Japan - Dec. 9, 2025 - "The Kyphosis Treatment Market reached US$ 1.3 billion in 2023 and is projected to grow to US$ 2.1 billion by 2031. The market is expected to expand at a CAGR of 6.2% during the forecast period 2024-2031."

The Kyphosis Treatment Market is driven by increasing incidence of postural kyphosis among younger populations due to prolonged device usage, rising geriatric spinal deformities, and growing adoption of advanced surgical technologies. Market growth is supported by expanding insurance coverage for spinal surgeries, rising awareness about early intervention, and continuous innovation in 3D-printed implants and robotic-assisted procedures.

➠ Download Your Sample Report Instantly - Corporate Email ID Required for Priority Access: https://www.datamintelligence.com/download-sample/kyphosis-treatment-market?praneetha

☛ Recent Industry Developments:
United States:
✅ December 2025:
Medtronic launched its next-generation Mazor X StealthTM robotic platform with enhanced kyphosis specific navigation protocols, targeting major U.S. spine centers. The company announced a US$ 140 million investment to expand robotic training facilities in Florida and California, accelerating adoption in complex deformity corrections.

✅ November 2025:
Stryker Corporation introduced the Everest Minimally Invasive Deformity System for posterior thoracic correction, receiving expanded FDA clearance for adolescent and adult kyphosis. The launch is backed by a US$ 95 million investment in surgeon training programs across North America.

✅ October 2025:
NuVasive (Globus Medical) released the Xeon PEEK-OPTIMATM hyperlordotic cages specifically designed for severe Scheuermann's kyphosis reconstruction. The company secured a US$ 70 million partnership with leading pediatric hospitals for clinical outcome studies.

Global:
✅ December 2025:
Zimmer Biomet signed a major supply agreement with a Japanese healthcare consortium for its TetherTM vertebral body tethering system targeting early onset kyphosis in Asia. The joint venture commits US$ 85 million to establish training centers in Tokyo and Singapore.

✅ November 2025:
DePuy Synthes (Johnson & Johnson) unveiled its UNLEASHTM expandable cage system for anterior column reconstruction in osteoporotic kyphosis, launching across Europe and Asia-Pacific. The company raised US$ 110 million to expand manufacturing in Switzerland and India.

✅ October 2025:
B. Braun Melsungen AG acquired a French med-tech startup specializing in 3D-printed patient specific rods for complex kyphosis correction, valued at US$ 55 million. This strengthens B. Braun's European deformity portfolio with customized implant solutions.

☛ Core Catalysts Behind Market Growth :
Rapidly increasing prevalence of Scheuermann's kyphosis in adolescents and degenerative/post traumatic kyphosis in the elderly is driving demand for both conservative and surgical treatments globally.

Technological advancements in minimally invasive surgery (MIS), robotic navigation, and 3D-printed personalized implants are significantly improving surgical outcomes and reducing recovery time.

Growing availability of bracing solutions, physiotherapy, and early screening programs, combined with rising healthcare expenditure in emerging economies, is accelerating market penetration.

Expanding reimbursement coverage for spinal deformity correction surgeries and increasing surgeon training programs are further boosting adoption of premium treatment modalities worldwide.

➠ Get Customization in the Report as per Your Requirements: https://www.datamintelligence.com/customize/kyphosis-treatment-market?praneetha

☛ Market Segmentation:
By Type :
Postural Kyphosis leads the market with 42% share, driven by its high prevalence among adolescents and young adults, often managed with non-invasive interventions and lifestyle modifications. Scheuermann's Kyphosis holds 35% share, supported by increasing clinical awareness, early diagnosis, and growing adoption of both conservative and surgical treatments. Congenital Kyphosis accounts for 18% share, typically requiring specialized care, surgical correction, and long term monitoring. Other rare kyphosis types represent 5% share, including post-traumatic and degenerative kyphosis, addressed through personalized therapeutic approaches.

By Treatment Type :
Drug based therapies dominate with 38% share, favored for pain management, anti inflammatory effects, and muscle relaxants for symptomatic relief. Device based treatments, including braces and orthotic supports, hold 34% share, widely adopted for postural correction and spinal stabilization. Other treatments, such as physical therapy, chiropractic care, and surgical interventions, account for 28% share, driven by increasing demand for multidisciplinary approaches and patient specific care plans.

By Distribution Channel :
Hospital pharmacies lead with 40% share, owing to accessibility for patients requiring prescription medications and device based therapies. Online pharmacies hold 30% share, rapidly expanding due to e-commerce growth, home delivery, and telehealth prescriptions. Retail pharmacies account for 20% share, supporting over the counter solutions, patient convenience, and community access. Other channels represent 10% share, including specialized orthopedic centers, rehabilitation clinics, and direct to consumer medical suppliers offering niche products for kyphosis management.

☛ Competitive Landscape:
The global Kyphosis Treatment market is highly competitive, characterized by continuous innovation in spinal implants, robotic systems, and non-invasive therapies to address diverse patient demographics and severity levels.

Medtronic plc leads with an estimated 24% share, powered by its comprehensive deformity portfolio including Mazor robotics and expansive titanium implant systems for complex reconstructions.

Stryker Corporation holds approximately 20% market share, dominating minimally invasive posterior solutions and benefiting from strong surgeon preference in North America and Europe.

DePuy Synthes (Johnson & Johnson) captures around 18%, excelling in anterior and expandable cage technologies for severe deformity correction worldwide.
Globus Medical, Inc. commands nearly 15% share, leading in expandable cages and robotic navigation through the ExcelsiusGPSTM platform.

Zimmer Biomet Holdings, Inc. maintains close to 12% market share, expanding rapidly in growth friendly systems for pediatric and adolescent kyphosis treatment.

Other Key Players:
B. Braun Melsungen AG, NuVasive, Inc., Orthofix Medical Inc., Alphatec Spine, Inc., SeaSpine Holdings Corporation.

➠ Purchase this report before year-end and unlock an exclusive 30% discount :

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=kyphosis-treatment-market?praneetha
(Purchase 2 or more Reports and get 50% Discount)

☛ Regional Analysis:
North America :
North America accounts for 42%, driven by high diagnosis rates, favorable reimbursement, advanced robotic infrastructure, and presence of leading spine companies in the U.S.

Europe :
Europe holds 28%, supported by aging population, well established healthcare systems, and high adoption of minimally invasive techniques in Germany, France, and the UK.

Asia-Pacific :
Asia-Pacific captures 20%, as the fastest growing region fueled by rising healthcare spending, increasing medical tourism in India and South Korea, and growing awareness of spinal deformities.

Latin America :
Latin America represents 6%, with accelerating growth in Brazil and Mexico through improving access to modern spinal implants and surgeon training programs.

Middle East & Africa :
Middle East & Africa account for 4%, driven by expanding private healthcare facilities in UAE and South Africa focusing on advanced deformity correction for medical tourism.

➠ Request for 2 Days FREE Trial Access: https://www.datamintelligence.com/reports-subscription

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.
✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Market Access Snapshots
✅ Emerging Risks & Market Volatility Analysis
✅ Quarterly Updated Reports
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

Company Name: DataM Intelligence 4Market Research LLP
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com/

DataM Intelligence is a global Market Research and Consulting firm providing comprehensive business insights and end-to-end solutions from research to consulting. We deliver actionable intelligence across 6,300+ reports spanning 40+ domains, empowering over 200 companies in 50+ countries. Our focus is on enabling clients to make data-driven decisions through robust methodologies, strategic foresight, and real-time market intelligence.

This release was published on openPR.